Merge Announces Addition of Business Leader to Board
February 21 2014 - 7:00AM
Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of
innovative enterprise imaging, interoperability and clinical
systems that seek to advance healthcare, today announced that its
Board of Directors has appointed William J. Devers Jr., president
of Devers Group Inc, as a director, effective immediately.
"We are very fortunate to have a new director with such a
considerable amount of business and software experience added to
the Merge Board of Directors," said Merge Chairman Dennis Brown.
"Bill's knowledge and vision will make him a significant
contributor to helping Merge execute the business plan it has
formulated to increase its market position in enterprise imaging
and interoperability. We believe that his strategic insights and
guidance will be critical as we look to increase shareholder
value."
Devers was the CEO of Trans Union Credit Information Company. He
left Trans Union in 1983 and started Devers Group as a vehicle for
his private investments. Devers group began with an acquisition
strategy, acquiring software companies in various vertical markets.
Prior to divestitures, Devers Group had revenues of approximately
$100 million and employed approximately 700 people.
Over the past 30 years, Mr. Devers has bought and sold over 20
software concerns, including sales to EDS, Klopotek (Berlin,
Germany), DBS Systems and others. Currently, Mr. Devers manages DGI
Private Equity Ventures, LLC, serves on the Board of Directors of
Ryan Specialty Group, Lurie Children's Hospital of Chicago, the Big
Shoulders Fund and is a less than 3% non-voting shareholder of
Merrick Ventures. In addition, Mr. Devers serves on an Advisory
Board at the University of Notre Dame and is a Trustee of the
Museum of Science and Industry in Chicago.
About Merge
Merge is a leading provider of innovative enterprise imaging,
interoperability and clinical systems that seek to advance
healthcare. Merge's enterprise and cloud-based technologies for
image intensive specialties provide access to any image, anywhere,
any time. Merge also provides clinical trials software with
end-to-end study support in a single platform and other intelligent
health data and analytics solutions. With solutions that have been
used by providers for more than 25 years, Merge is helping to
reduce costs, improve efficiencies and enhance the quality of
healthcare worldwide. For more information, visit merge.com and
follow us @MergeHealthcare.
Cautionary Notice Regarding Forward-Looking
Statements
The matters discussed in this news release may include
forward-looking statements, which could involve a number of risks
and uncertainties. When used in this press release, the words
"will," "believes," "intends," "anticipates," "expects" and similar
expressions are intended to identify forward-looking statements.
Actual results could differ materially from those expressed in, or
implied by, such forward-looking statements. Except as expressly
required by the federal securities laws, the Company undertakes no
obligation to update such factors or to publicly announce the
results of any of the forward-looking statements.
CONTACT: Media Contact:
Jennifer Jawor
Vice President, Corporate Marketing
312.565.6825
jennifer.jawor@merge.com
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jul 2023 to Jul 2024